ID CAC1B_MOUSE Reviewed; 2327 AA. AC O55017; Q60609; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1998, sequence version 1. DT 27-MAR-2024, entry version 207. DE RecName: Full=Voltage-dependent N-type calcium channel subunit alpha-1B; DE AltName: Full=Brain calcium channel III; DE Short=BIII; DE AltName: Full=Calcium channel, L type, alpha-1 polypeptide isoform 5; DE AltName: Full=Voltage-gated calcium channel subunit alpha Cav2.2; GN Name=Cacna1b; Synonyms=Cach5, Cacnl1a5, Cchn1a; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain; RA Hong T., Birnbaumer L.; RT "Nucleotide sequence polymorphism of mouse alpha1 B."; RL Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS NB1 AND NB2), AND VARIANT ALA-414 INS. RC TISSUE=Neuroblastoma; RX PubMed=8307146; DOI=10.1016/0014-5793(94)80105-3; RA Coppola T., Waldmann R., Borsotto M., Heurteaux C., Romey G., Mattei M.-G., RA Lazdunski M.; RT "Molecular cloning of a murine N-type calcium channel alpha 1 subunit. RT Evidence for isoforms, brain distribution, and chromosomal localization."; RL FEBS Lett. 338:1-5(1994). RN [3] RP INTERACTION WITH RIMS1. RC TISSUE=Brain; RX PubMed=11438518; DOI=10.1074/jbc.m100929200; RA Coppola T., Magnin-Luethi S., Perret-Menoud V., Gattesco S., Schiavo G., RA Regazzi R.; RT "Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, RT and synaptotagmin."; RL J. Biol. Chem. 276:32756-32762(2001). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200; RA Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.; RT "Comprehensive identification of phosphorylation sites in postsynaptic RT density preparations."; RL Mol. Cell. Proteomics 5:914-922(2006). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain cortex; RX PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200; RA Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., RA Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., RA Panse C., Schlapbach R., Mansuy I.M.; RT "Qualitative and quantitative analyses of protein phosphorylation in naive RT and stimulated mouse synaptosomal preparations."; RL Mol. Cell. Proteomics 6:283-293(2007). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411; SER-745; SER-748; RP SER-783; SER-1058; SER-2056; SER-2212; SER-2221 AND SER-2244, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP METHYLATION [LARGE SCALE ANALYSIS] AT ARG-22, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=24129315; DOI=10.1074/mcp.o113.027870; RA Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M., RA Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V., RA Bedford M.T., Comb M.J.; RT "Immunoaffinity enrichment and mass spectrometry analysis of protein RT methylation."; RL Mol. Cell. Proteomics 13:372-387(2014). RN [8] RP INTERACTION WITH FMR1. RX PubMed=24709664; DOI=10.1038/ncomms4628; RA Ferron L., Nieto-Rostro M., Cassidy J.S., Dolphin A.C.; RT "Fragile X mental retardation protein controls synaptic vesicle exocytosis RT by modulating N-type calcium channel density."; RL Nat. Commun. 5:3628-3628(2014). CC -!- FUNCTION: Voltage-sensitive calcium channels (VSCC) mediate the entry CC of calcium ions into excitable cells and are also involved in a variety CC of calcium-dependent processes, including muscle contraction, hormone CC or neurotransmitter release, gene expression, cell motility, cell CC division and cell death. This alpha-1B subunit gives rise to N-type CC calcium currents. N-type calcium channels belong to the 'high-voltage CC activated' (HVA) group. They are involved in pain signaling. Calcium CC channels containing alpha-1B subunit may play a role in directed CC migration of immature neurons. Mediates Ca(2+) release probability at CC hippocampal neuronal soma and synaptic terminals (By similarity). CC {ECO:0000250|UniProtKB:Q02294}. CC -!- ACTIVITY REGULATION: Is specifically blocked by omega-conotoxin GVIA CC (By similarity). Is specifically blocked by omega-conotoxin MVIIA CC (ziconotide) (By similarity). Is insensitive to dihydropyridines (DHP). CC {ECO:0000250|UniProtKB:Q00975, ECO:0000250|UniProtKB:Q02294}. CC -!- SUBUNIT: Multisubunit complex consisting of alpha-1, alpha-2, beta and CC delta subunits in a 1:1:1:1 ratio. The channel activity is directed by CC the pore-forming and voltage-sensitive alpha-1 subunit. In many cases, CC this subunit is sufficient to generate voltage-sensitive calcium CC channel activity. The auxiliary subunits beta and alpha-2/delta linked CC by a disulfide bridge regulate the channel activity. Interacts with CC RIMS1 (PubMed:11438518). Interacts with FMR1 (via C-terminus); this CC interaction induces a decrease in the number of presynaptic functional CC CACNA1B channels at the cell surface (PubMed:24709664). CC {ECO:0000269|PubMed:11438518, ECO:0000269|PubMed:24709664}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q00975}; Multi- CC pass membrane protein {ECO:0000250|UniProtKB:Q00975}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=NB1; CC IsoId=O55017-1; Sequence=Displayed; CC Name=NB2; CC IsoId=O55017-2; Sequence=VSP_000883; CC -!- TISSUE SPECIFICITY: Widespread expression throughout the brain. Highest CC levels in pyramidal cell layers C1, C2 and C3 of the hippocampus, in CC the dentate gyrus, in the cortex layers 2 et 4, in the subiculum and CC the habenula. CC -!- DOMAIN: Each of the four internal repeats contains five hydrophobic CC transmembrane segments (S1, S2, S3, S5, S6) and one positively charged CC transmembrane segment (S4). S4 segments probably represent the voltage- CC sensor and are characterized by a series of positively charged amino CC acids at every third position. CC -!- PTM: Phosphorylated in vitro by CaM-kinase II, PKA, PKC and CGPK. CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the calcium channel alpha-1 subunit CC (TC 1.A.1.11) family. CACNA1B subfamily. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAB60437.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF042317; AAB97840.1; -; mRNA. DR EMBL; U04999; AAB60437.1; ALT_FRAME; mRNA. DR CCDS; CCDS38065.1; -. [O55017-1] DR PIR; S41080; S41080. DR RefSeq; NP_001035993.1; NM_001042528.2. [O55017-1] DR AlphaFoldDB; O55017; -. DR BMRB; O55017; -. DR SMR; O55017; -. DR BioGRID; 198431; 20. DR IntAct; O55017; 2. DR MINT; O55017; -. DR STRING; 10090.ENSMUSP00000037416; -. DR ChEMBL; CHEMBL3637936; -. DR TCDB; 1.A.1.11.9; the voltage-gated ion channel (vic) superfamily. DR GlyCosmos; O55017; 3 sites, No reported glycans. DR GlyGen; O55017; 5 sites, 1 O-linked glycan (2 sites). DR iPTMnet; O55017; -. DR PhosphoSitePlus; O55017; -. DR SwissPalm; O55017; -. DR MaxQB; O55017; -. DR PaxDb; 10090-ENSMUSP00000037416; -. DR ProteomicsDB; 273879; -. [O55017-1] DR ProteomicsDB; 273880; -. [O55017-2] DR Antibodypedia; 32538; 161 antibodies from 28 providers. DR DNASU; 12287; -. DR Ensembl; ENSMUST00000041342.12; ENSMUSP00000037416.6; ENSMUSG00000004113.20. [O55017-1] DR GeneID; 12287; -. DR KEGG; mmu:12287; -. DR UCSC; uc008ipe.2; mouse. [O55017-1] DR AGR; MGI:88296; -. DR CTD; 774; -. DR MGI; MGI:88296; Cacna1b. DR VEuPathDB; HostDB:ENSMUSG00000004113; -. DR eggNOG; KOG2301; Eukaryota. DR GeneTree; ENSGT00940000155275; -. DR InParanoid; O55017; -. DR OMA; DPNKECA; -. DR OrthoDB; 1110761at2759; -. DR TreeFam; TF312805; -. DR Reactome; R-MMU-112308; Presynaptic depolarization and calcium channel opening. DR BioGRID-ORCS; 12287; 2 hits in 79 CRISPR screens. DR ChiTaRS; Cacna1b; mouse. DR PRO; PR:O55017; -. DR Proteomes; UP000000589; Chromosome 2. DR RNAct; O55017; Protein. DR Bgee; ENSMUSG00000004113; Expressed in supraoptic nucleus and 134 other cell types or tissues. DR ExpressionAtlas; O55017; baseline and differential. DR GO; GO:0043679; C:axon terminus; ISO:MGI. DR GO; GO:0030425; C:dendrite; IDA:MGI. DR GO; GO:0043198; C:dendritic shaft; ISO:MGI. DR GO; GO:0098978; C:glutamatergic synapse; ISO:MGI. DR GO; GO:0016020; C:membrane; IDA:MGI. DR GO; GO:0043025; C:neuronal cell body; IDA:MGI. DR GO; GO:0048786; C:presynaptic active zone; IDA:SynGO. DR GO; GO:0032991; C:protein-containing complex; ISO:MGI. DR GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:MGI. DR GO; GO:0005891; C:voltage-gated calcium channel complex; IDA:MGI. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0008331; F:high voltage-gated calcium channel activity; IDA:MGI. DR GO; GO:0051721; F:protein phosphatase 2A binding; ISO:MGI. DR GO; GO:0005245; F:voltage-gated calcium channel activity; IMP:MGI. DR GO; GO:0099626; F:voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels; ISO:MGI. DR GO; GO:0070509; P:calcium ion import; ISO:MGI. DR GO; GO:0098703; P:calcium ion import across plasma membrane; IBA:GO_Central. DR GO; GO:0070588; P:calcium ion transmembrane transport; IMP:MGI. DR GO; GO:0006816; P:calcium ion transport; IMP:MGI. DR GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central. DR GO; GO:0051649; P:establishment of localization in cell; IMP:MGI. DR GO; GO:0007626; P:locomotory behavior; IMP:MGI. DR GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:MGI. DR GO; GO:0007269; P:neurotransmitter secretion; IMP:MGI. DR GO; GO:0001956; P:positive regulation of neurotransmitter secretion; ISO:MGI. DR GO; GO:0008217; P:regulation of blood pressure; IMP:MGI. DR GO; GO:0051924; P:regulation of calcium ion transport; IMP:MGI. DR GO; GO:0150037; P:regulation of calcium-dependent activation of synaptic vesicle fusion; ISO:MGI. DR GO; GO:0008016; P:regulation of heart contraction; IMP:MGI. DR GO; GO:1904645; P:response to amyloid-beta; ISO:MGI. DR GO; GO:0014070; P:response to organic cyclic compound; ISO:MGI. DR GO; GO:0048265; P:response to pain; IMP:MGI. DR GO; GO:0033574; P:response to testosterone; ISO:MGI. DR Gene3D; 1.10.287.70; -; 4. DR Gene3D; 6.10.250.2180; -; 1. DR Gene3D; 6.10.250.2500; -; 1. DR Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4. DR InterPro; IPR002048; EF_hand_dom. DR InterPro; IPR031649; GPHH_dom. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR014873; VDCC_a1su_IQ. DR InterPro; IPR005447; VDCC_N_a1su. DR InterPro; IPR002077; VDCCAlpha1. DR InterPro; IPR027359; Volt_channel_dom_sf. DR PANTHER; PTHR45628; VOLTAGE-DEPENDENT CALCIUM CHANNEL TYPE A SUBUNIT ALPHA-1; 1. DR PANTHER; PTHR45628:SF6; VOLTAGE-DEPENDENT N-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1B; 1. DR Pfam; PF08763; Ca_chan_IQ; 1. DR Pfam; PF16905; GPHH; 1. DR Pfam; PF00520; Ion_trans; 4. DR PRINTS; PR00167; CACHANNEL. DR PRINTS; PR01631; NVDCCALPHA1. DR SMART; SM01062; Ca_chan_IQ; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 4. DR PROSITE; PS50222; EF_HAND_2; 1. DR Genevisible; O55017; MM. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Calcium; Calcium channel; KW Calcium transport; Disulfide bond; Glycoprotein; Ion channel; KW Ion transport; Membrane; Metal-binding; Methylation; Nucleotide-binding; KW Phosphoprotein; Reference proteome; Repeat; Transmembrane; KW Transmembrane helix; Transport; Voltage-gated channel. FT CHAIN 1..2327 FT /note="Voltage-dependent N-type calcium channel subunit FT alpha-1B" FT /id="PRO_0000053922" FT TOPO_DOM 1..90 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 91..114 FT /note="Helical; Name=S1 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 115..131 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 132..152 FT /note="Helical; Name=S2 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 153..163 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 164..182 FT /note="Helical; Name=S3 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 183..187 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 188..211 FT /note="Helical; Name=S4 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 212..221 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 222..244 FT /note="Helical; Name=S5 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 245..331 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 332..356 FT /note="Helical; Name=S6 of repeat I" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 357..482 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 483..501 FT /note="Helical; Name=S1 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 502..511 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 512..534 FT /note="Helical; Name=S2 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 535..544 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 545..566 FT /note="Helical; Name=S3 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 567..573 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 574..586 FT /note="Helical; Name=S4 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 587..604 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 605..630 FT /note="Helical; Name=S5 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 631..682 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 683..709 FT /note="Helical; Name=S6 of repeat II" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 710..1140 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1141..1159 FT /note="Helical; Name=S1 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1160..1167 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1168..1192 FT /note="Helical; Name=S2 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1193..1206 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1207..1231 FT /note="Helical; Name=S3 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1232..1237 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1238..1258 FT /note="Helical; Name=S4 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1259..1276 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1277..1296 FT /note="Helical; Name=S5 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1297..1383 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1384..1409 FT /note="Helical; Name=S6 of repeat III" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1410..1464 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1465..1483 FT /note="Helical; Name=S1 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1484..1491 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1492..1516 FT /note="Helical; Name=S2 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1517..1526 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1527..1548 FT /note="Helical; Name=S3 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1549..1554 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1555..1573 FT /note="Helical; Name=S4 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1574..1592 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1593..1612 FT /note="Helical; Name=S5 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1613..1674 FT /note="Extracellular" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TRANSMEM 1675..1698 FT /note="Helical; Name=S6 of repeat IV" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT TOPO_DOM 1699..2327 FT /note="Cytoplasmic" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT REPEAT 82..359 FT /note="I" FT REPEAT 468..712 FT /note="II" FT REPEAT 1126..1412 FT /note="III" FT REPEAT 1449..1702 FT /note="IV" FT DOMAIN 1715..1750 FT /note="EF-hand" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT REGION 1..37 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 379..396 FT /note="Binding to the beta subunit" FT /evidence="ECO:0000250" FT REGION 801..1015 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1042..1066 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1972..2193 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2230..2249 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2273..2292 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 801..821 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 874..937 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 957..1015 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1050..1066 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2005..2022 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2038..2054 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2085..2108 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 2152..2193 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 451..458 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT BINDING 544 FT /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo- FT inositol-4,5-bisphosphate)" FT /ligand_id="ChEBI:CHEBI:58456" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT BINDING 584 FT /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo- FT inositol-4,5-bisphosphate)" FT /ligand_id="ChEBI:CHEBI:58456" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT BINDING 587 FT /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo- FT inositol-4,5-bisphosphate)" FT /ligand_id="ChEBI:CHEBI:58456" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT BINDING 1728 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT BINDING 1734 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT BINDING 1739 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000305" FT SITE 314 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 663 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 1358 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT SITE 1646 FT /note="Calcium ion selectivity and permeability" FT /evidence="ECO:0000250" FT MOD_RES 22 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0007744|PubMed:24129315" FT MOD_RES 411 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 745 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 748 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 783 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16452087, FT ECO:0007744|PubMed:21183079" FT MOD_RES 1058 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 2056 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 2212 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 2221 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 2244 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT CARBOHYD 256 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000250|UniProtKB:Q00975" FT CARBOHYD 1554 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1666 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 756 FT /note="A -> AFVKQTRGTVSRSSSVSSVNSP (in isoform NB2)" FT /evidence="ECO:0000303|PubMed:8307146" FT /id="VSP_000883" FT VARIANT 414 FT /note="D -> DA" FT /evidence="ECO:0000269|PubMed:8307146" FT CONFLICT 238 FT /note="A -> G (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 645 FT /note="N -> I (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 757..759 FT /note="RQQ -> QE (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 880 FT /note="A -> P (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1128 FT /note="L -> F (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1173 FT /note="K -> E (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1185 FT /note="F -> C (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1227..1230 FT /note="Missing (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1388 FT /note="F -> L (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1549 FT /note="A -> AET (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1615 FT /note="I -> S (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1636 FT /note="L -> I (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1657 FT /note="G -> D (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1802..1837 FT /note="Missing (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1942 FT /note="A -> G (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1949 FT /note="G -> D (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1963 FT /note="A -> L (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1979 FT /note="E -> D (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 1994 FT /note="P -> L (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2021 FT /note="H -> D (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2075 FT /note="A -> AA (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2141 FT /note="T -> A (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2168 FT /note="S -> I (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2309 FT /note="S -> N (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2313 FT /note="R -> G (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" FT CONFLICT 2316 FT /note="H -> A (in Ref. 2; AAB60437)" FT /evidence="ECO:0000305" SQ SEQUENCE 2327 AA; 261481 MW; AD42CDD38482895A CRC64; MVRFGDELGG RYGGTGGGER ARGGGAGGAG GPGQGGLPPG QRVLYKQSIA QRARTMALYN PIPVKQNCFT VNRSLFVFSE DNVVRKYAKR ITEWPPFEYM ILATIIANCI VLALEQHLPD GDKTPMSERL DDTEPYFIGI FCFEAGIKII ALGFVFHKGS YLRNGWNVMD FVVVLTGILA TAGTDFDLRT LRAVRVLRPL KLVSGIPSLQ VVLKSIMKAM VPLLQIGLLL FFAILMFAII GLEFYMGKFH KACFPNSTDT EPVGDFPCGK DPPARQCDGD TECREYWPGP NFGITNFDNI LFAILTVFQC ITMEGWTDIL YNTNDAAGNT WNWLYFIPLI IIGSFFMLNL VLGVLSGEFA KERERVENRR AFLKLRRQQQ IERELNGYLE WIFKAEEVML AEEDKNAEEK SPLDVLKRAA TKKSRNDLIH AEEGEDRFVD LCAVGSPFAR ASLKSGKTES SSYFRRKEKM FRFFIRRMVK AQSFYWVVLC VVALNTLCVA MVHYNQPQRL TTALYFAEFV FLGLFLTEMS LKMYGLGPRS YFRSSFNCFD FGVIVGSIFE VVWAAIKPGT SFGISVLRAL RLLRIFKVTK YWNSLRNLVV SLLNSMKSII SLLFLLFLFI VVFALLGMQL FGGQFNFQDE TPTTNFDTFP AAILTVFQIL TGEDWNAVMY HGIESQGGVS KGMFSSFYFI VLTLFGNYTL LNVFLAIAVD NLANAQELTK DEEEMEEAAN QKLALQKAKE VAEVSPMSAA NISIAARQQN SAKARSVWEQ RASQLRLQNL RASCEALYSE MDPEERLRYA STRHVRPDMK THMDRPLVVE PGRDGLRGPV GSKSKPEGTE ATESADLPRR HHRHRDRDKT SATAPAGGEQ DRTESTETGA REERARPRRS HSKETPGADT QVRCERSRRH HRRGSPEEAT EREPRRHRAH RHAQDSSKEG TAPVLVPKGE RRARHRGPRT GPREAENNEE PTRRHRARHK VPPTLQPPER EAAEKESNAV EGDKETRNHQ PKEPHCDLEA IAVTGVGPLH MLPSTCLQKV DEQPEDADNQ RNVTRMGSQP SDPSTTVHVP VTLTGPPGET PVVPSGNMNL EGQAEGKKEA EADDVLRRGP RPIVPYSSMF CLSPTNLLRR FCHYIVTMRY FEMVILVVIA LSSIALAAED PVRTDSFRNN ALKYMDYIFT GVFTFEMVIK MIDLGLLLHP GAYFRDLWNI LDFIVVSGAL VAFAFSSFMG GSKGKDINTI KSLRVLRVLR PLKTIKRLPK LKAVFDCVVN SLKNVLNILI VYMLFMFIFA VIAVQLFKGK FFYCTDESKE LERDCRGQYL DYEKEEVEAQ PRQWKKYDFH YDNVLWALLT LFTVSTGEGW PMVLKHSVDA TYEEQGPSPG FRMELSIFYV VYFVVFPFFF VNIFVALIII TFQEQGDKVM SECSLEKNER ACIDFAISAK PLTRYMPQNK QSFQYKTWTF VVSPPFEYFI MAMIALNTVV LMMKFYDAPY EYELMLKCLN IVFTSMFSME CILKIIAFGV LNYFRDAWNV FDFVTVLGSI TDILVTEIAN NFINLSFLRL FRAARLIKLL RQGYTIRILL WTFVQSFKAL PYVCLLIAML FFIYAIIGMQ VFGNIALDDD TSINRHNNFR TFLQALMLLF RSATGEAWHE IMLSCLGNRA CDPHANASEC GSDFAYFYFV SFIFLCSFLM LNLFVAVIMD NFEYLTRDSS ILGPHHLDEF IRVWAEYDPA ACGRISYNDM FEMLKHMSPP LGLGKKCPAR VAYKRLVRMN MPISNEDMTV HFTSTLMALI RTALEIKLAP AGTKQHQCDA ELRKEISSVW ANLPQKTLDL LVPPHKPDEM TVGKVYAALM IFDFYKQNKT TRDQTHQAPG GLSQMGPVSL FHPLKATLEQ TQPAVLRGAR VFLRQKSATS LSNGGAIQTQ ESGIKESLSW GTQRTQDALY EARAPLERGH SAEIPVGQSG TLAVDVQMQN MTLRGPDGEP QPGLESQGRA ASMPRLAAET QPAPNASPMK RSISTLAPRP HGTQLCSTVL DRPPPSQASH HHHHRCHRRR DKKQRSLEKG PSLSVDPEGA PSTAAGPGLP HGEGSTACRR DRKQERGRSQ ERRQPSSSSS EKQRFYSCDR FGSREPPQLM PSLSSHPTSP TAALEPAPHP QGSGSVNGSP LMSTSGASTP GRGGRRQLPQ TPLTPRPSIT YKTANSSPVH FAEGQSGLPA FSPGRLSRGL SEHNALLQKE PLSQPLAPGS RIGSDPYLGQ RLDSEASAHT LPEDTLTFEE AVATNSGRSS RTSYVSSLTS QSHPLRRVPN GYHCTLGLST GVRARHSYHH PDQDHWC //